Meeting
2015 Genitourinary Cancers Symposium
The impact of time to metastasis on survival in treatment-naïve prostate cancer patients.
Authors
Shusuke Akamatsu
Vancouver Prostate Centre and Department of Urologic Sciences, Vancouver, BC, Canada
Shusuke Akamatsu , Kenny Lynch , Peter Black , Martin Gleave , Larry Goldenberg , Kim N. Chi , Alan So
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Prostate Cancer - Advanced Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 212)
DOI
10.1200/jco.2015.33.7_suppl.212
Abstract #
212
Poster Bd #
B5
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
EORTC GUCG 2238 De-escalate: A pragmatic trial to revisit intermittent androgen-deprivation therapy in metastatic hormone-naïve prostate cancer in the era of new AR pathway inhibitors.
First Author: Guillaume Grisay
Poster
2023 ASCO Genitourinary Cancers Symposium
Prognostic value of pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
First Author: Zhipeng Wang
Poster
2023 ASCO Genitourinary Cancers Symposium
Multicenter population-level analysis of systemic therapy use in metastatic or recurrent prostate cancer.
First Author: Heba Mohamed
Poster
2021 Genitourinary Cancers Symposium
SPOP mutations in prostate cancer: Clinical and genomic features.
First Author: Mari Nakazawa